274 related articles for article (PubMed ID: 35589014)
1. Long noncoding RNAs (lncRNAs) in pancreatic cancer progression.
Ashrafizadeh M; Rabiee N; Kumar AP; Sethi G; Zarrabi A; Wang Y
Drug Discov Today; 2022 Aug; 27(8):2181-2198. PubMed ID: 35589014
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA GSTM3TV2 upregulates LAT2 and OLR1 by competitively sponging let-7 to promote gemcitabine resistance in pancreatic cancer.
Xiong G; Liu C; Yang G; Feng M; Xu J; Zhao F; You L; Zhou L; Zheng L; Hu Y; Wang X; Zhang T; Zhao Y
J Hematol Oncol; 2019 Sep; 12(1):97. PubMed ID: 31514732
[TBL] [Abstract][Full Text] [Related]
3.
Terashima M; Ishimura A; Wanna-Udom S; Suzuki T
J Biol Chem; 2018 Nov; 293(47):18016-18030. PubMed ID: 30262664
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
5. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance.
Jiang XY; Zhu QC; Zhang XJ; Duan T; Feng J; Sui XB; Sun XN; Mou YP
Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):128-139. PubMed ID: 36543619
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer.
Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B
Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma.
Li Z; Jiang P; Li J; Peng M; Zhao X; Zhang X; Chen K; Zhang Y; Liu H; Gan L; Bi H; Zhen P; Zhu J; Li X
Oncogene; 2018 Jul; 37(28):3822-3838. PubMed ID: 29643475
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer.
Xie W; Chu M; Song G; Zuo Z; Han Z; Chen C; Li Y; Wang ZW
Semin Cancer Biol; 2022 Aug; 83():303-318. PubMed ID: 33207266
[TBL] [Abstract][Full Text] [Related]
9. LncRNA SNHG12 contributes proliferation, invasion and epithelial-mesenchymal transition of pancreatic cancer cells by absorbing miRNA-320b.
Cao W; Zhou G
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32432698
[TBL] [Abstract][Full Text] [Related]
10. Development of epithelial-mesenchymal transition-related lncRNA signature for predicting survival and immune microenvironment in pancreatic cancerwithexperiment validation.
Gao Y; Liu J; Cai B; Chen Q; Wang G; Lu Z; Jiang K; Miao Y
Bioengineered; 2021 Dec; 12(2):10553-10567. PubMed ID: 34854360
[TBL] [Abstract][Full Text] [Related]
11. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract][Full Text] [Related]
12. The involvement of lncRNAs in the development and progression of pancreatic cancer.
Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNAs: role and contribution in pancreatic cancer.
Ramya Devi KT; Karthik D; Mahendran T; Jaganathan MK; Hemdev SP
Transcription; 2021 Feb; 12(1):12-27. PubMed ID: 34036896
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
15. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.
Deng SJ; Chen HY; Ye Z; Deng SC; Zhu S; Zeng Z; He C; Liu ML; Huang K; Zhong JX; Xu FY; Li Q; Liu Y; Wang CY; Zhao G
Oncogene; 2018 Nov; 37(44):5811-5828. PubMed ID: 29970904
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability.
Eptaminitaki GC; Stellas D; Bonavida B; Baritaki S
Drug Resist Updat; 2022 Dec; 65():100866. PubMed ID: 36198236
[TBL] [Abstract][Full Text] [Related]
18. Long non‑coding RNA CTBP1‑AS2 upregulates USP22 to promote pancreatic carcinoma progression by sponging miR‑141‑3p.
Zhang M; Ma S; Li X; Yu H; Tan Y; He J; Wei X; Ma J
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039872
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia.
Richards EJ; Zhang G; Li ZP; Permuth-Wey J; Challa S; Li Y; Kong W; Dan S; Bui MM; Coppola D; Mao WM; Sellers TA; Cheng JQ
J Biol Chem; 2015 Mar; 290(11):6857-67. PubMed ID: 25605728
[TBL] [Abstract][Full Text] [Related]
20. Roles of long noncoding RNAs in colorectal cancer metastasis.
Li H; Ma SQ; Huang J; Chen XP; Zhou HH
Oncotarget; 2017 Jun; 8(24):39859-39876. PubMed ID: 28418892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
